Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NDRA
NDRA logo

NDRA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy ENDRA Life Sciences Inc (NDRA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
5.500
1 Day change
-0.36%
52 Week Range
11.960
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

NDRA is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is in pre-market weakness, there is no supportive news or catalyst, no positive proprietary trading signal, and the short-term pattern points to downside over the next month. While the moving averages are currently bullish, the MACD is negative and contracting, which weakens the setup. Given the user's impatience and desire to act now rather than wait, the clearer decision is to avoid buying and not commit capital here.

Technical Analysis

NDRA is trading at 5.3 in pre-market, down 3.99%, which shows immediate weakness. The trend structure is mixed: SMA_5 is above SMA_20 and SMA_200, which is bullish on trend, but MACD histogram is -0.0156 and still contracting, signaling fading momentum. RSI_6 at 57.143 is neutral and does not indicate an oversold entry. Price is below the pivot of 5.491 and only slightly above S1 at 5.052, so support is nearby but not yet confirmed. The short-term modeled trend suggests limited upside near term and a negative monthly drift.

Positive Catalysts

  • No recent news catalysts were reported. The only mild positive is that the moving averages remain stacked bullishly (SMA_5 > SMA_20 > SMA_200), which suggests the broader trend has not fully broken down.

Neutral/Negative Catalysts

  • Pre-market price is down 3.99%. No news in the recent week means there is no fresh event-driven support. No AI Stock Picker signal and no SwingMax signal are present. Hedge funds and insiders are neutral with no significant trading trends, and the modeled trend shows a possible -5.19% move over the next month.

Financial Performance

No usable latest-quarter financial snapshot was provided, so there is no reliable quarterly growth assessment available for ENDRA Life Sciences Inc.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so Wall Street sentiment cannot be confirmed from the dataset. Based on the available information, pros would point to the bullish moving-average structure, but cons dominate because there is no catalyst, no favorable trading signal, and momentum is weakening.

Wall Street analysts forecast NDRA stock price to rise
1 Analyst Rating
Wall Street analysts forecast NDRA stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 5.520
sliders
Low
30
Averages
30
High
30
Current: 5.520
sliders
Low
30
Averages
30
High
30
No data

No data

People Also Watch